BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Thursday, June 4, 2026
Home » Newsletters » BioWorld Science

BioWorld Science

July 8, 2019

View Archived Issues

Syndecan-2 increases cell invasiveness in lung adenocarcinoma

Read More

PK and safety of a new formulation of nemiralisib inhaled as dry powder in healthy individuals

Read More

Antimicrobial peptide LL-37 shows promising efficacy against S. aureus biofilms

Read More

Tau-targeted PET with flortaucipir in Alzheimer's disease: evaluation of tau and cognitive changes

Read More

Novel PIK3CD gene variant linked to activated PI3Kdelta syndrome

Read More

CXCL10 gene promoter -1447A>G polymorphism as a new biomarker of susceptibility to malaria

Read More

Rare frameshift mutation in SERPINA3 associated with generalized pustular psoriasis

Read More

New target improves metabolism

Read More

Chaperone gene therapy delays ALS

Read More

Merck & Co., Idenix Pharmaceuticals describe HIV-1 reverse transcriptase/ribonuclease H inhibitors

Read More

New hematopoietic prostaglandin D2 synthase inhibitors discovered at GlaxoSmithKline

Read More

Gedeon Richter presents vasopressin V1A receptor antagonists

Read More

Leukotriene C4 production inhibitors patented by Shaanxi University of Science & Technology

Read More

Almirall identifies acetyl-CoA carboxylase inhibitors

Read More

New wound-healing antibacterial EBC-1013 presented

Read More

Focus V approved in China for soft tissue sarcoma

Read More

Eisai and University of Dundee collaborate on PROTAC research

Read More

Boehringer Ingelheim studies safety and pharmacokinetics of BI-706321 in healthy volunteers

Read More

New phase III trial studies capivasertib + paclitaxel for locally advanced or metastatic TNBC

Read More

TDP-43 screen identifies potential therapeutics for ALS and frontotemporal dementia

Read More

[18F]MNI-1126 detects synaptic density loss in Alzheimer's disease and Parkinson's disease patients

Read More

4D pharma initiates phase I/II study of MRx-4DP0004 for asthma

Read More

FDA accepts Celyad's IND application for autologous NKG2D-based CAR-T cell therapy CYAD-02

Read More

Intra-Cellular Therapies reports topline phase III data on lumateperone in bipolar depression

Read More

DMC recommends continuation of phase Ib study of AVB-500 in ovarian cancer

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 3, 2026.
  • Pancreas 3D hologram

    ASCO 2026: A revolution in pancreatic cancer

    BioWorld
    At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for June 2, 2026
  • Liver over digital lens background

    EASL 2026: Emerging liver disease targets to watch

    BioWorld
    At the recently concluded European Association for the Study of the Liver meeting, presentations underscored how increasingly granular insights into liver...
  • Bispecific antibodies with heavy chain in green and pink, light chain in blue and yellow

    ASCO 2026: PD-(L)1 x VEGF bispecifics fight it out

    BioWorld
    Multiple companies are chasing Akeso Inc. and Summit Therapeutics Inc. in the battle to potentially dethrone Keytruda (pembrolizumab, Merck & Co. Inc.) as the top...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing